Tissue factor encryption

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 26, Issue 3, 2006, Pages 456-461

  Bach, Ronald R ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b VA MEDICAL CENTER   (United States)

Author keywords

Coagulation; Cytosolic calcium; Factor VII; Phosphatidylserine; Tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 7; CALCIUM; ENZYME PRECURSOR; PHOSPHATIDYLSERINE; PROCOAGULANT; THROMBOPLASTIN;

BLOOD CLOTTING; CALCIUM TRANSPORT; CELL SURFACE; CYTOSOL; EXPOSURE; HEMOSTASIS; HUMAN; LIPID RAFT; MONOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; THROMBOCYTE;

ANIMALS; BLOOD COAGULATION; BLOOD PLATELETS; HUMANS; MONOCYTES; THROMBOPLASTIN;

EID: 33646578193     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000202656.53964.04     Document Type: Review

References (71)

1. Morawitz P. Die chemie der blutergerinnung. Ergebnisse der Physiologie. 1905;4:307-422.
2. Howell WH. Theories of blood coagulation. Physiol Rev. 1935;15:435-470.
3. Bach RR. Initiation of coagulation by tissue factor. CRC Crit Rev Biochem. 1988;23:339-368.
4. Bächli E. History of tissue factor. 2000;110:248-255.
5. Drake TA. Morrissey JH. Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis Am J Path. 1989;134:1087-1097.
6. Key NS. Slungaard A. Dandelet L. Nelson SC. Moertel C Styles LA Kuypers FA Bach RR Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood. 1998;91:4216-4223.
7. Giesen PL. Rauch U. Bohrmann B. Kling D. Roque M Fallon JT Badimon JJ Himber J Riederer MA Nemerson Y Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A. 1999;96:2311-2315.
8. Rauch U. Bonderman D. Bohrmann B. Badimon JJ. Himber J Riederer MA Nemerson Y Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood. 2000;96:170-175.
9. Ozcan M. Morton CT. Solovey A. Dandelet L. Bach RR Hebbel RP Slungaard A Key NS Whole blood tissue factor procoagulant activity remains detectable during severe aplasia following bone marrow and peripheral blood stem cell transplantation. Thromb Haemo. 2001;85:250-255.
10. Zillmann A. Luther T. Muller I. Kotzsch M. Spannagl M Kauke T Oelschlagel U Zahler S Engelmann B Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation. Biochem Biophys Res Comm. 2001;281:603-609.
11. Balasubramanian V. Grabowski E. Bini A. Nemerson Y. Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions. Blood. 2002;100:2787-2792.
12. Muller I. Klocke A. Alex M. Kotzsch M. Luther T Morgenstern E Zieseniss S Zahler S Preissner K Engelmann B Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J. 2003;17:476-478.
13. Bach RR. Johnson GJ Long JR. Key NS. Intravascular tissue factor procoagulant activity increases following joint replacement surgery (Abstract). J Thromb Haemo. 2003;1(S1):P0536.
14. Bach R. Rifkin DB. Expression of tissue factor procoagulant activity: regulation by cytosolic calcium. Proc Natl Acad Sci U S A. 1990;87:6995-6999.
15. Broze GJ Jr. Binding of human factor VII and VIIa to monocytes. J Clin Invest. 1982;70:526-535.
16. Fair DS. MacDonald MJ. Cooperative interaction between factor VII and cell surface-expressed tissue factor. J Biol Chem. 1987;262:11692-11698.
17. Le DT. Rapaport SI. Rao LV. Relations between factor VIIa binding and expression of factor VIIa/tissue factor catalytic activity on cell surfaces. J Biol Chem. 1992;267:15447-15454.
18. Maynard JR. Heckman CA. Pitlick FA. Nemerson Y. Association of tissue factor activity with the surface of cultured cells. J Clin Invest. 1975;55:814-824.
19. Maynard JR. Dreyer BE. Stemerman MB. Pitlick FA. Tissue-factor coagulant activity of cultured human endothelial and smooth muscle cells and fibroblasts. Blood. 1977;50:387-396.
20. Carson SD. Archer PG. Tissue factor activity in HeLa cells measured with a continuous chromogenic assay and ELISA reader. Thromb Res. 1986;41:185-195.
21. Bach RR. Moldow CF. Mechanism of tissue factor activation on HL-60 cells. Blood. 1997;89:3270-3276.
22. Bach RR. Mechanism of tissue factor activation on cells. Blood Coagulation & Fibrinolysis. 1998;9:37-43.
23. Wolberg AS. Monroe DM. Roberts HR. Hoffman MR. Tissue factor de-encryption: ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanisms. Blood Coagulation & Fibrinolysis. 1999;10:201-210.
24. Otnaess AB. Prydz H. Bjorklid E. Berre A. Phospholipase C from Bacillus cereus and its use in studies of tissue thromboplastin. Euro J Biochem. 1972;27:238-243.
25. Carson SD. Johnson DR. Consecutive enzyme cascades: complement activation at the cell surface triggers increased tissue factor activity. Blood. 1990;76:361-367.
26. Greeno EW. Bach RR. Moldow CF. Apoptosis is associated with increased cell surface tissue factor procoagulant activity. Lab Invest. 1996;75:281-289.
27. Carson SD. Manifestation of cryptic fibroblast tissue factor occurs at detergent concentrations which dissolve the plasma membrane. Blood Coagulation & Fibrinolysis. 1996;7:303-313.
28. 2+ entry are required for disruption of phosphatidylserine asymmetry and de-encryption of tissue factor procoagulant activity on the HL-60 cell surface (Abstract). Blood. 2001;98:501.
29. Zwaal RF. Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 1997;89:1121-1132.
30. Zwaal RF. Comfurius P. Bevers EM. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci. 2005;62:971-988.
31. Comfurius P. Senden JM. Tilly RH. Schroit AJ. Bevers EM Zwaal RF Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochem Biophys Acta. 1990;1026:153-158.
32. Kunzelmann-Marche C. Satta N. Toti F. Zhang Y. Nawroth PP Morrissey JH Freyssinet JM The influence exerted by a restricted phospholipid microenvironment on the expression of tissue factor activity at the cell plasma membrane surface. Thromb Haemo. 2000;83:282-289.
33. Lentz BR. Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Prog in Lipid Res. 2003;42:423-438.
34. Hoffman M. Monroe DM 3rd. A cell-based model of hemostasis. Thrombo Haemo. 2001;85:958-965.
35. Hathcock JJ. Rusinova E. Gentry RD. Andree H. Nemerson Y Phospholipid regulates the activation of FX by TF:VIIa via substrate and product interactions. Biochemistry. 2005;44:8187-8197.
36. Thiagarajan P. Tait JF. Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles. J Biol Chem. 1991;266:24302-24307.
37. Fadok VA. Veolker D. Campbell PA. Cohen JJ. Bratton DL Henson PM Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 1992;148:2207-2216.
38. Rosing J. Bevers EM. Comfurius P. Hemker HC. van Dieijen G Weiss HJ Zwaal RF Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder. Blood. 1985;65:1557-1561.
39. Williamson P. Christie A. Kohlin T. Schlegel RA. Comfurius P Harmsma M Zwaal RF Bevers EM Phospholipid scramblase activation pathways in lymphocytes. Biochemistry. 2001;40:8065-8072.
40. Banner DW. D'Arcy A. Chene C. Winkler FK. Guha A. Konigsberg WH Nemerson Y Kirchhofer D The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature. 1996;380:41-46.
41. Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci U S A. 1990;87:6934-6938.
42. de Vos AM. Ultsch M. Kossiakoff AA. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science. 1992;255:306-312.
43. Livnah O. Stura EA. Johnson DL. Middleton SA. Mulcahy LS Wrighton NC Dower WJ Jolliffe LK Wilson IA Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 28 Å. Science. 1996;273:464-471.
44. Roy S. Paborsky LR. Vehar GA. Self-association of tissue factor as revealed by chemical crosslinking. J Biol Chem. 1991;266:4665-4668.
45. Norledge BV. Petrovan RJ. Ruf W. Olson AJ. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis. Proteins. 2003;53:640-648.
46. Martin DM. Boys CW. Ruf W. Tissue factor: molecular recognition and cofactor function. FASEB J. 1995;9:852-859.
47. Chen SW. Pellequer JL. Schved IF. Giansily-Blaizot M. Model of a ternary complex between activated factor VII, tissue factor and factor IX. Thromb Haemo. 2002;88:74-82.
48. Roy S. Hass PE. Bourell JH. Henzel WJ. Vehar GA Lysine residues 165 and 166 are essential for the cofactor function of tissue factor. J Biol Chem. 1991;266:22063-22066.
49. Ruf W. Miles DJ. Rehemtulla A. Edgington TS. Cofactor residues lysine 165 and 166 are critical for protein substrate recognition by the tissue factor-factor VIIa protease complex. J Biol Chem. 1992;267:6375-6381.
50. Muller YA. Ultsch MH. Kelley RF. de Vos AM. Structure of the extracellular domain of human tissue factor: location of the factor VIIa binding site. Biochemistry. 1994;33:10864-10870.
51. Harlos K. Martin DM. O'Brien DP. Jones EY. Stuart DI Polikarpov I Miller A Tuddenham EG Boys CW Crystal structure of the extracellular region of human tissue factor. Nature. 1994;370:662-666.
52. Doñate F. Kelly CR. Ruf W. Edgington TS. Dimerization of tissue factor supports solution-phase autoactivation of factor VII without influencing proteolytic activation of factor X. Biochemistry. 2000;39:11467-11476.
53. Waxman E. Ross JBA. Laue TM. Guha A. Thiruvikraman SV. Lin TC. Konigsberg WH. Nemerson Y. Biochemistry. 1992;31:3998-4003.
54. Ruf W. Rehemtulla A. Edgington TS. Phospholipid-independent and - dependent interaction required for tissue factor receptor and cofactor function. J Biol Chem. 1991;266:2158-2166.
55. Dietzen DJ. Page KL. Tetzloff TA. Lipid rafts are necessary for tonic inhibition of cellular tissue factor procoagulant activity. Blood. 2004;103:3038-3044.
56. Mandal SK. Iakhiaev A. Pendurthi UR. Rao LV. Acute cholesterol depletion impairs functional expression of tissue factor in fibroblasts: modulation of tissue factor activity by membrane cholesterol. Blood. 2005;105:153-160.
57. del Conde I. Shrimpton CN. Thiagarajan P. Lopez IA. Tissue factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood. 2005;106:1604-1611.
58. Bach R. Konigsberg WH. Nemerson Y. Human tissue factor contains thioester-linked palmitate and stearate on the cytoplasmic half-cystine. Biochemistry. 1988;27:4227-4231.
59. Zacharias DA. Violin JD. Newton AC. Tsien RY. Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science. 2002;296:913-916.
60. Simons K. Ehehalt R. Cholesterol, lipid rafts, and disease. J Clin Invest. 2002;110:597-603.
61. Dorfleutner A. Ruf W. Regulation of tissue factor cytoplasmic domain phosphorylation by palmitoylation. Blood. 2003;102:3998-4005.
62. Belting M. Dorrell MI Sandgren S. Aguilar E. Ahamed J Dorfleutner A Carmeliet P Mueller BM Friedlander M Ruf W Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nature Medicine. 2004;10:502-509.
63. Belting M. Ahamed I. Ruf W. Signaling of the tissue factor pathway in angiogenesis and cancer. Arterio Thromb Vasc Biol. 2005;25:1545-1550.
64. LaRosa JC. Pleiotropic effects of statins and their clinical significance. Am J Cardio. 2001;88:291-293.
65. Undas A. Brummel-Ziedins KE. Mann KG. Statins and blood coagulation. Arterioscler Throm Vasc Biol. 2005;25:287-294.
66. Kunzelmann-Marche C. Freyssinet IM. Martinez MC. Loss of plasma membrane phospholipid asymmetry requires raft integrity. Role of transient receptor potential channels and ERK pathway. J Biol Chem. 2002;277:19876-19881.
67. Neuenschwander PF. Fiore MM. Morrissey JH. Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogen-cofactor complexes. Implications of a two-dimensional enzyme kinetic mechanism. J Biol Chem. 1993;268:21489-21492.
68. Morrissey JH. Macik BG. Neuenschwander PF. Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood. 1993;81:734-744.
69. Bach R Tissue factor de-encryption (Abstract). J Thromb Haemo. 2003;1(S1):SY17.
70. Rao LV. Rapaport SI Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation. Proc Natl Acad Sci U S A. 1988;85:6687-6691.
71. Hedner U. Recombinant factor VIIa (Novoseven) as a hemostatic agent. Seminars in Hematology. 2001;38:43-47.